190 related articles for article (PubMed ID: 38201285)
1. Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma.
Lorenzo-Guerra SL; Codina-Martínez H; Suárez-Fernández L; Cabal VN; García-Marín R; Riobello C; Vivanco B; Blanco-Lorenzo V; Sánchez-Fernández P; López F; Llorente JL; Hermsen MA
Cells; 2023 Dec; 13(1):. PubMed ID: 38201285
[TBL] [Abstract][Full Text] [Related]
2. Recurrent Loss of SMARCA4 in Sinonasal Teratocarcinosarcoma.
Rooper LM; Uddin N; Gagan J; Brosens LAA; Magliocca KR; Edgar MA; Thompson LDR; Agaimy A; Bishop JA
Am J Surg Pathol; 2020 Oct; 44(10):1331-1339. PubMed ID: 32520761
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Molecular Profiling of Sinonasal Teratocarcinosarcoma Highlights Recurrent SMARCA4 Inactivation and CTNNB1 Mutations.
Rooper LM; Agaimy A; Gagan J; Simpson RHW; Thompson LDR; Trzcinska AM; Ud Din N; Bishop JA
Am J Surg Pathol; 2023 Feb; 47(2):224-233. PubMed ID: 36206446
[TBL] [Abstract][Full Text] [Related]
4. Fine needle aspiration cytology of metastatic SMARCA4-deficient sinonasal teratocarcinosarcoma: First report in literature.
Gopakumar A; Kakkar A; Kaur K; Sikka K; Thakar A; Sharma A; Jain D
Diagn Cytopathol; 2023 Apr; 51(4):E129-E136. PubMed ID: 36680532
[TBL] [Abstract][Full Text] [Related]
5. SMARCA4/BRG1-Deficient Sinonasal Carcinoma.
Kakkar A; Ashraf SF; Rathor A; Adhya AK; Mani S; Sikka K; Jain D
Arch Pathol Lab Med; 2022 Sep; 146(9):1122-1130. PubMed ID: 34871352
[TBL] [Abstract][Full Text] [Related]
6. Targeted next-generation sequencing reveals activating CTNNB1 mutations in SMARCA4/BRG1-deficient sinonasal carcinomas: a report of two new cases and a brief review of the literature with an emphasis on histogenesis.
Zhao M; Ma T; He X; Ge M
Virchows Arch; 2023 Feb; 482(2):453-460. PubMed ID: 36396744
[TBL] [Abstract][Full Text] [Related]
7. SALL-4 and Beta-Catenin Expression in Sinonasal Teratocarcinosarcoma.
Compton ML; Lewis JS; Faquin WC; Cipriani NA; Shi Q; Ely KA
Head Neck Pathol; 2022 Mar; 16(1):229-235. PubMed ID: 34106411
[TBL] [Abstract][Full Text] [Related]
8. PIK3CA somatic mutation in sinonasal teratocarcinosarcoma.
Belardinilli F; De Vincentiis L; D'Ecclesia A; Giannini G; Giangaspero F; Corsi A
Auris Nasus Larynx; 2021 Jun; 48(3):530-534. PubMed ID: 32389511
[TBL] [Abstract][Full Text] [Related]
9. A unique uterine cervical "teratocarcinosarcoma": a case report.
Ito K; Yano M; Ogasawara A; Miwa M; Kozawa E; Yasuda M
Diagn Pathol; 2019 Nov; 14(1):122. PubMed ID: 31684979
[TBL] [Abstract][Full Text] [Related]
10. Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: SWI/SNF-deficient Sinonasal Neoplasms: An Overview.
Agaimy A
Head Neck Pathol; 2022 Mar; 16(1):168-178. PubMed ID: 35307773
[TBL] [Abstract][Full Text] [Related]
11. Familial rhabdoid tumour 'avant la lettre'--from pathology review to exome sequencing and back again.
Witkowski L; Lalonde E; Zhang J; Albrecht S; Hamel N; Cavallone L; May ST; Nicholson JC; Coleman N; Murray MJ; Tauber PF; Huntsman DG; Schönberger S; Yandell D; Hasselblatt M; Tischkowitz MD; Majewski J; Foulkes WD
J Pathol; 2013 Sep; 231(1):35-43. PubMed ID: 23775540
[TBL] [Abstract][Full Text] [Related]
12. SWI/SNF-deficient head and neck neoplasms: An overview.
Agaimy A; Bishop JA
Semin Diagn Pathol; 2021 May; 38(3):175-182. PubMed ID: 33663878
[TBL] [Abstract][Full Text] [Related]
13. Sinonasal teratocarcinosarcoma: a clinicopathologic and immunohistochemical study of 6 cases.
Fatima SS; Minhas K; Din NU; Fatima S; Ahmed A; Ahmad Z
Ann Diagn Pathol; 2013 Aug; 17(4):313-8. PubMed ID: 23462185
[TBL] [Abstract][Full Text] [Related]
14. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
[TBL] [Abstract][Full Text] [Related]
15. Germline mutations of SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type and in SMARCA4-deficient undifferentiated uterine sarcoma: Clinical features of a single family and comparison of large cohorts.
Connor YD; Miao D; Lin DI; Hayne C; Howitt BE; Dalrymple JL; DeLeonardis KR; Hacker MR; Esselen KM; Shea M
Gynecol Oncol; 2020 Apr; 157(1):106-114. PubMed ID: 31954538
[TBL] [Abstract][Full Text] [Related]
16. SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma.
Kolin DL; Dong F; Baltay M; Lindeman N; MacConaill L; Nucci MR; Crum CP; Howitt BE
Mod Pathol; 2018 Sep; 31(9):1442-1456. PubMed ID: 29700418
[TBL] [Abstract][Full Text] [Related]
17. Sinonasal teratocarcinosarcoma with yolk sac elements: a neoplasm of somatic or germ cell origin?
Thomas J; Adegboyega P; Iloabachie K; Mooring JW; Lian T
Ann Diagn Pathol; 2011 Apr; 15(2):135-9. PubMed ID: 20952296
[TBL] [Abstract][Full Text] [Related]
18. SMARCA4 inactivating mutations cause concomitant Coffin-Siris syndrome, microphthalmia and small-cell carcinoma of the ovary hypercalcaemic type.
Errichiello E; Mustafa N; Vetro A; Notarangelo LD; de Jonge H; Rinaldi B; Vergani D; Giglio SR; Morbini P; Zuffardi O
J Pathol; 2017 Sep; 243(1):9-15. PubMed ID: 28608987
[TBL] [Abstract][Full Text] [Related]
19. Sinonasal teratocarcinosarcoma: report of a case with review of literature and treatment outcome.
Wei S; Carroll W; Lazenby A; Bell W; Lopez R; Said-Al-Naief N
Ann Diagn Pathol; 2008 Dec; 12(6):415-25. PubMed ID: 18995206
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic study of sinonasal teratocarcinosarcoma and its contrast with olfactory neuroblastoma].
Li X; Liu HG; Xie XJ; Han YD; Li M
Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):458-64. PubMed ID: 19035117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]